Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Giardia lamblia | Hypothetical protein | 0.1462 | 0.3449 | 0.5 |
Brugia malayi | Thioredoxin family protein | 0.1462 | 0.3449 | 1 |
Mycobacterium ulcerans | hypothetical protein | 0.1462 | 0.3449 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.1462 | 0.3449 | 1 |
Mycobacterium ulcerans | putative transglutaminase-like protein | 0.1462 | 0.3449 | 0.5 |
Mycobacterium leprae | Conserved hypothetical protein | 0.1462 | 0.3449 | 0.5 |
Mycobacterium ulcerans | hypothetical protein | 0.1462 | 0.3449 | 0.5 |
Echinococcus granulosus | Transcription factor JmjC domain containing protein | 0.0626 | 0.1038 | 0.3011 |
Giardia lamblia | Transglutaminase/protease, putative | 0.1462 | 0.3449 | 0.5 |
Trichomonas vaginalis | peptide N-glycanase, putative | 0.1462 | 0.3449 | 0.5 |
Mycobacterium tuberculosis | Conserved protein | 0.1462 | 0.3449 | 0.5 |
Echinococcus multilocularis | Transglutaminase | 0.1462 | 0.3449 | 1 |
Mycobacterium tuberculosis | Hypothetical protein | 0.1462 | 0.3449 | 0.5 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.1462 | 0.3449 | 0.5 |
Loa Loa (eye worm) | jmjC domain-containing protein | 0.0395 | 0.0371 | 1 |
Mycobacterium tuberculosis | Long conserved protein | 0.1462 | 0.3449 | 0.5 |
Echinococcus multilocularis | Transcription factor, JmjC domain containing protein | 0.0626 | 0.1038 | 0.3011 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.1462 | 0.3449 | 0.5 |
Mycobacterium ulcerans | transglutaminase family protein | 0.1462 | 0.3449 | 0.5 |
Echinococcus granulosus | Transglutaminase | 0.1462 | 0.3449 | 1 |
Mycobacterium leprae | Conserved hypothetical protein | 0.1462 | 0.3449 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.